# Microbot Medical Inc.: filings

MBOT · Nasdaq · CIK 883975 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mbot.md) · [Financials](/companies/mbot/financials.md) · [Filings](/companies/mbot/filings.md) · [Insiders](/companies/mbot/insiders.md)

## Reports and events: 543 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 405, 4 311, 10-Q 53, 424B3 46, 424B5 39, 3 27, 10-K 18, DEF 14A 18, EFFECT 17, SC 13G/A 17, DEFA14A 16, UPLOAD 15, CORRESP 14, SC 13G 14, SC 13D/A 12, 8-K/A 10, D 10, S-1/A 9, S-3 9, 4/A 8, POS AM 7, PRE 14A 7, S-1 7, S-8 6, SC 13D 6, 10-K/A 5, 5 5, SCHEDULE 13G/A 5, S-3/A 4, SCHEDULE 13G 4, ARS 2, CT ORDER 2, NT 10-Q 2, RW 2, DEFM14A 1, DEFR14A 1, DFAN14A 1, FWP 1, NT 10-K 1, PREM14A 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 08:30 ET | [8-K](/filings/0001493152-26-048182.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048182 |
| 2026-10-20 | 08:30 ET | [8-K](/filings/0001493152-26-047702.md) | 5.08 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047702 |
| 2026-10-06 | 08:30 ET | [8-K](/filings/0001493152-26-045866.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045866 |
| 2026-09-28 | 06:24 ET | [8-K](/filings/0001493152-26-044429.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044429 |
| 2026-08-11 | 10:28 ET | [8-K](/filings/0001493152-26-037031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037031 |
| 2026-08-11 | 09:15 ET | [10-Q](/filings/0001493152-26-037009.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037009 |
| 2026-08-07 | 16:30 ET | [8-K](/filings/0001493152-26-036600.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-036600 |
| 2026-07-21 | 08:30 ET | [8-K](/filings/0001493152-26-034014.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034014 |
| 2026-07-07 | 08:30 ET | [8-K](/filings/0001493152-26-032260.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032260 |
| 2026-06-30 | 08:30 ET | [8-K](/filings/0001493152-26-031205.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-031205 |
| 2026-06-25 | 08:30 ET | [8-K](/filings/0001493152-26-030038.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030038 |
| 2026-06-23 | 08:30 ET | [8-K](/filings/0001493152-26-029709.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-029709 |
| 2026-06-16 | 08:30 ET | [8-K](/filings/0001493152-26-028824.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028824 |
| 2026-06-09 | 08:30 ET | [8-K](/filings/0001493152-26-027861.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027861 |
| 2026-06-02 | 08:30 ET | [8-K](/filings/0001493152-26-026769.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026769 |
| 2026-05-26 | 08:30 ET | [8-K](/filings/0001493152-26-025171.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025171 |
| 2026-05-15 | 12:03 ET | [8-K](/filings/0001493152-26-023493.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023493 |
| 2026-05-14 | 08:30 ET | [8-K](/filings/0001493152-26-022886.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022886 |
| 2026-05-13 | 17:16 ET | [10-Q](/filings/0001493152-26-022792.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022792 |
| 2026-05-05 | 08:30 ET | [8-K](/filings/0001493152-26-021231.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-021231 |
| 2026-04-30 | 08:30 ET | [8-K](/filings/0001493152-26-019775.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-019775 |
| 2026-04-22 | 08:30 ET | [8-K](/filings/0001493152-26-018453.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018453 |
| 2026-04-14 | 08:30 ET | [8-K](/filings/0001493152-26-016484.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016484 |
| 2026-04-13 | 08:30 ET | [8-K](/filings/0001493152-26-016293.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016293 |
| 2026-04-10 | 17:00 ET | [8-K](/filings/0001493152-26-016198.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016198 |
| 2026-03-26 | 16:30 ET | [10-K](/filings/0001493152-26-012935.md) | Annual report, period 2025-12-31 | 0001493152-26-012935 |
| 2026-03-26 | 08:35 ET | [8-K](/filings/0001493152-26-012812.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012812 |
| 2026-03-24 | 08:30 ET | [8-K](/filings/0001493152-26-012281.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012281 |
| 2026-03-17 | 09:27 ET | [8-K](/filings/0001493152-26-010446.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-010446 |
| 2026-03-10 | 08:30 ET | [8-K](/filings/0001493152-26-009454.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009454 |
| 2026-03-04 | 08:30 ET | [8-K](/filings/0001493152-26-008782.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008782 |
| 2026-03-03 | 09:00 ET | [8-K](/filings/0001493152-26-008658.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008658 |
| 2026-02-24 | 17:00 ET | [8-K](/filings/0001493152-26-007900.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-007900 |
| 2026-02-24 | 08:30 ET | [8-K](/filings/0001493152-26-007827.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007827 |
| 2026-02-19 | 08:30 ET | [8-K](/filings/0001493152-26-007429.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007429 |
| 2026-02-12 | 08:30 ET | [8-K](/filings/0001493152-26-006310.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006310 |
| 2026-02-05 | 08:30 ET | [8-K](/filings/0001493152-26-005206.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005206 |
| 2026-01-12 | 08:30 ET | [8-K](/filings/0001493152-26-001234.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-001234 |
| 2025-11-26 | 08:30 ET | [8-K](/filings/0001493152-25-025069.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025069 |
| 2025-11-12 | 16:17 ET | [10-Q](/filings/0001493152-25-021929.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021929 |
| 2025-11-05 | 08:30 ET | [8-K](/filings/0001493152-25-020815.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020815 |
| 2025-10-16 | 08:30 ET | [8-K](/filings/0001493152-25-018260.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018260 |
| 2025-10-14 | 08:42 ET | [8-K](/filings/0001493152-25-017941.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017941 |
| 2025-10-07 | 08:15 ET | [8-K](/filings/0001493152-25-017212.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017212 |
| 2025-10-03 | 16:30 ET | [8-K](/filings/0001493152-25-016866.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-016866 |
| 2025-10-01 | 09:00 ET | [8-K](/filings/0001493152-25-016484.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-016484 |
| 2025-09-23 | 08:37 ET | [8-K](/filings/0001493152-25-014557.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-014557 |
| 2025-09-19 | 16:30 ET | [8-K](/filings/0001493152-25-014263.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-014263 |
| 2025-09-16 | 17:04 ET | [8-K](/filings/0001493152-25-013743.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013743 |
| 2025-09-09 | 09:01 ET | [8-K](/filings/0001641172-25-026942.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-026942 |

Page 1 of 11. [Older](/companies/mbot/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:31 ET. No prices; not investment advice.